Detalhe da pesquisa
1.
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.
Am J Respir Crit Care Med
; 209(8): 960-972, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127850
2.
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study.
BMC Pulm Med
; 24(1): 221, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704538
3.
The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach.
Respir Res
; 24(1): 121, 2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131265
4.
Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.
Respir Res
; 24(1): 293, 2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37990197
5.
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.
BMC Med Res Methodol
; 22(1): 150, 2022 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35614467
6.
Incorporating external evidence on between-trial heterogeneity in network meta-analysis.
Stat Med
; 38(8): 1321-1335, 2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488475
7.
Implementing informative priors for heterogeneity in meta-analysis using meta-regression and pseudo data.
Stat Med
; 35(29): 5495-5511, 2016 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27577523
8.
Two new methods to fit models for network meta-analysis with random inconsistency effects.
BMC Med Res Methodol
; 16: 87, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465416
9.
Methods for calculating confidence and credible intervals for the residual between-study variance in random effects meta-regression models.
BMC Med Res Methodol
; 14: 103, 2014 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25196829
10.
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Cochrane Database Syst Rev
; (2): CD010271, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24532092
11.
Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany.
BMJ Open Respir Res
; 11(1)2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555102
12.
Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.
Int J Chron Obstruct Pulmon Dis
; 19: 225-241, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38259591
13.
Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy.
Eur J Intern Med
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729787
14.
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.
Heart
; 110(10): 702-709, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182279
15.
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis.
Pharmacotherapy
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721837
16.
EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies.
BMJ Open
; 13(4): e070022, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185641
17.
Alternative weighting schemes when performing matching-adjusted indirect comparisons.
Res Synth Methods
; 12(3): 333-346, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33131206
18.
Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis.
Front Oncol
; 11: 672916, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34381708
19.
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer.
Eur J Cancer
; 157: 415-423, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597975
20.
Agreement was moderate between data-based and opinion-based assessments of biases affecting randomized trials within meta-analyses.
J Clin Epidemiol
; 125: 16-25, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416338